<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
    <channel>
        <title><![CDATA[Sweden Herald - Novo]]></title>
        <description><![CDATA[The latest Sweden Herald stories about Novo, in English.]]></description>
        <link>https://swedenherald.com/organisation/novo</link>
        <generator>RSS for Node and Next.js</generator>
        <lastBuildDate>Sun, 15 Nov 2026 17:13:43 GMT</lastBuildDate>
        <atom:link href="https://swedenherald.com/rss/organisation/novo.xml" rel="self" type="application/rss+xml"/>
        <copyright><![CDATA[Sweden Herald]]></copyright>
        <language><![CDATA[en-US]]></language>
        <ttl>60</ttl>
        <item>
            <title><![CDATA[Eli Lilly Raises Full-Year Forecast After Beating Profit and Sales Expectations]]></title>
            <description><![CDATA[The American pharmaceutical giant Eli Lilly, Danish Novo's main competitor, is beating profit expectations and raising its forecast for the year.]]></description>
            <link>https://swedenherald.com/article/eli-lilly-beats-profit-forecasts-and-raises-2026-revenue-outlook-to-91-billion92-billion</link>
            <guid isPermaLink="true">https://swedenherald.com/article/eli-lilly-beats-profit-forecasts-and-raises-2026-revenue-outlook-to-91-billion92-billion</guid>
            <category><![CDATA[Business News]]></category>
            <dc:creator><![CDATA[Sweden Herald]]></dc:creator>
            <pubDate>Thu, 29 Oct 2026 11:05:26 GMT</pubDate>
            <enclosure url="https://static.swedenherald.com/4caf78d3-71d7-4474-b6a9-27f8429e8dfb/4caf78d3-71d7-4474-b6a9-27f8429e8dfb.jpg" length="0" type="image/jpeg"/>
            <media:content url="https://static.swedenherald.com/4caf78d3-71d7-4474-b6a9-27f8429e8dfb/4caf78d3-71d7-4474-b6a9-27f8429e8dfb.jpg" medium="image" type="image/jpeg" width="1200" height="675"/>
        </item>
        <item>
            <title><![CDATA[Novo cuts Wegovy price by 20% in Sweden as subsidy bid continues]]></title>
            <description><![CDATA[Pharmaceutical giant Novo is cutting the price of its weight loss drug Wegovy by 20 percent on the Swedish market. At the same time, the company is working to get the drug subsidized.]]></description>
            <link>https://swedenherald.com/article/novo-cuts-wegovy-price-by-20-in-sweden-as-subsidy-bid-continues</link>
            <guid isPermaLink="true">https://swedenherald.com/article/novo-cuts-wegovy-price-by-20-in-sweden-as-subsidy-bid-continues</guid>
            <category><![CDATA[Business News]]></category>
            <dc:creator><![CDATA[Sweden Herald]]></dc:creator>
            <pubDate>Thu, 01 Oct 2026 04:00:13 GMT</pubDate>
            <enclosure url="https://static.swedenherald.com/99d44caa-6e7e-4819-a012-2084cd3c5c05/99d44caa-6e7e-4819-a012-2084cd3c5c05.jpg" length="0" type="image/jpeg"/>
            <media:content url="https://static.swedenherald.com/99d44caa-6e7e-4819-a012-2084cd3c5c05/99d44caa-6e7e-4819-a012-2084cd3c5c05.jpg" medium="image" type="image/jpeg" width="1200" height="675"/>
        </item>
    </channel>
</rss>